Evidence map›Paper›PMID 22994806›Full record

ArticleBMC molecular biology2012

A MultiSite Gateway™ vector set for the functional analysis of genes in the model Saccharomyces cerevisiae.

Astrid Nagels Durand, Tessa Moses, Rebecca De Clercq, Alain Goossens, Laurens Pauwels

Open access · hybridAbstract read
In one paragraph

Article in BMC molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Astrid Nagels DurandDepartment of Plant Systems Biology, VIB, Technologiepark 927, B-9052, Gent, Belgium.
Tessa Moses
Rebecca De Clercq
Alain Goossens
Laurens Pauwels
VIB-UGent Center for Plant Systems Biology · BEGhent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecombinatorial cloning using the Gateway™ technology has been the method of choice for high-throughput omics projects, resulting in the availability of entire ORFeomes in Gateway™ compatible vectors. The MultiSite Gateway™ system allows combining multiple genetic fragments such as promoter, ORF and epitope tag in one single reaction. To date, this technology has not been accessible in the yeast Saccharomyces cerevisiae, one of the most widely used experimental systems in molecular biology, due to the lack of appropriate destination vectors.

resultsHere, we present a set of three-fragment MultiSite Gateway™ destination vectors that have been developed for gene expression in S. cerevisiae and that allow the assembly of any promoter, open reading frame, epitope tag arrangement in combination with any of four auxotrophic markers and three distinct replication mechanisms. As an example of its applicability, we used yeast three-hybrid to provide evidence for the assembly of a ternary complex of plant proteins involved in jasmonate signalling and consisting of the JAZ, NINJA and TOPLESS proteins.

conclusionOur vectors make MultiSite Gateway™ cloning accessible in S. cerevisiae and implement a fast and versatile cloning method for the high-throughput functional analysis of (heterologous) proteins in one of the most widely used model organisms for molecular biology research.

Indexed as

Cloning, MolecularArabidopsisArabidopsis ProteinsGenetic VectorsModels, BiologicalRecombinant Fusion ProteinsSaccharomyces cerevisiaeArabidopsis ProteinsRecombinant Fusion Proteins

Identifiers

PMID22994806
PMCPMC3519679
OpenAlexW2068799564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.